Abpro Holdings, Inc. (ABPO): Depreciation & Amortization
$21.0K
Year ended 2025-12-31
$12.0K
Trailing 12 months to 2026-06-30
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $21.0K | -71.6% | 2026-04-15, From 2025-01-01 |
| 2024-12-31 | $74.0K | -73.5% | 2026-04-15, From 2024-01-01 |
| 2023-12-31 | $279.0K | n/a | 2025-04-15, From 2023-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Abpro Holdings, Inc. (ABPO) | 2025-12-31 | $21.0K | -71.6% |
| Zeo ScientifiX, Inc. (ZEOX) | 2025-10-31 | $73.0K | -1.4% |
| BioCardia, Inc. (BCDA) | 2025-12-31 | $24.0K | -64.2% |
| VivoSim Labs, Inc. (VIVS) | 2026-03-31 | $215.0K | -19.2% |
| Creative Medical Technology Holdings, Inc. (CELZ) | 2024-12-31 | $56.0K | 0.0% |
| Calidi Biotherapeutics, Inc. (CLDI) | 2025-12-31 | $1.65M | +7.6% |
| Scinai Immunotherapeutics Ltd. (SCNI) | 2025-12-31 | $1.42M | -13.8% |
| BioAtla, Inc. (BCAB) | 2025-12-31 | $373.0K | -59.7% |
| Outlook Therapeutics, Inc. (OTLK) | 2025-09-30 | $117.1K | +2.8% |
Compare ABPO, ZEOX, BCDA, VIVS side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗